ஆண்டு மருத்துவ ஜெநெடிக்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஆண்டு மருத்துவ ஜெநெடிக்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஆண்டு மருத்துவ ஜெநெடிக்ஸ் Today - Breaking & Trending Today

LogicBio Announces Presentation of Retrospective Study of Disease Course in Pediatric Patients with Severe Methylmalonic Acidemia

LogicBio Announces Presentation of Retrospective Study of Disease Course in Pediatric Patients with Severe Methylmalonic Acidemia
- Data presented at ACMG meeting evaluate disease progression in non-transplanted patients and children receiving liver transplantation
News provided by
Share this article
Share this article
LEXINGTON, Mass., May 3, 2021 /PRNewswire/ LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today announced results from a retrospective study of the disease course in pediatric patients living with severe methylmalonic acidemia (MMA) caused by a deficiency of the mitochondrial enzyme methylmalonyl-CoA mutase (MMUT). The study results were recently highlighted in a poster presentation at the American College of Medical Genetic and Genomics (ACMG) Annual Clinical Genetics Meeting. ....

Daniel Gruskin , Bill Berry , Berry Company Public Relations , Gilmartin Group , American College Of Medical Genetic , Logicbio Therapeutics Inc , Logicbio Therapeutics , American College , Medical Genetic , Annual Clinical Genetics , Methylmalonic Acidemia , Bio Therapeutics , ர சி து பெர்ரி , பெர்ரி நிறுவனம் பொது உறவுகள் , கில்மார்டின் குழு , அமெரிக்கன் கல்லூரி , ஆண்டு மருத்துவ ஜெநெடிக்ஸ் , உயிர் சிகிச்சை ,

Study finds risk-causing genetic changes in nearly 1 in 6 patients with colorectal cancer

Share this article
Share this article
SAN FRANCISCO, April 15, 2021 /PRNewswire/ Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced research showing one in six people with colorectal cancer harbor genetic changes that are known to substantially increase the risk for cancer, especially in patients who were younger when diagnosed. The findings are the latest from a
landmark study of genetic testing across many solid tumor cancers and were presented at the 2021 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting.
Colorectal cancer is one of the most common types of cancer. Recently we ve seen an unfortunate increase in incidence among people younger than 50 years old. Improving our understanding of who is at risk and implementing appropriate screening strategies is essential to ensuring these cancers are caught and treated earlier when outcomes are typically better, said Robert Nussbaum, M ....

United States , Laura Dangelo , Robert Nussbaum , Exchange Commission , Invitae Corporation , American Cancer Society , American College Of Medical Genetics , Medical Genetics , Annual Clinical Genetics , Private Securities Litigation Reform Act , Annual Report , ஒன்றுபட்டது மாநிலங்களில் , லாரா டாங்கெலோ , ராபர்ட் நுஸிசிபோும் , பரிமாற்றம் தரகு , அமெரிக்கன் புற்றுநோய் சமூகம் , அமெரிக்கன் கல்லூரி ஆஃப் மருத்துவ ஜெநெடிக்ஸ் , மருத்துவ ஜெநெடிக்ஸ் , ஆண்டு மருத்துவ ஜெநெடிக்ஸ் , ப்ரைவேட் பத்திரங்கள் வழக்கு சீர்திருத்தம் நாடகம் , ஆண்டு அறிக்கை ,